Methods of Inducing Immune Tolerance Using Immunotoxins


The invention concerns immunotoxins and methods of using the immunotoxins for the treatment of rejection response in a patient, including graft-versus-host disease and transplantation of organs, tissues and cells into a host. In a specific embodiment of the invention, the transplant involves pancreatic islet cells. The immunotoxins are targeted via an antibody that is specific to T cells. This allows the specific ablation of resting T cells, resulting in an accentuation of immune tolerizing responses and an increased tolerance to transplants and grafts. The toxin portion of the immunotoxin is genetically engineered to maintain bioactivity when recombinantly produced in Pichia pastoris. Data are available in transgenic animals expressing human CD3epsilon which supports the effects of the immunotoxin against T cells.

Potential Commercial Applications: Competitive Advantages:
  • Use of immunotoxins decreases T cell population, allowing greater host immune tolerance of transplants and grafts.
  • Specific method for increasing immune tolerance to pancreatic islet transplants.
 
  • Specificity of the immunotoxin avoids the killing of other cells, reducing side-effects associated with other mechanisms of treatment (X-ray and cyclophosphamide) such as infection and induced malignancy.
  • A GMP production process for the immunotoxin has already been successfully implemented.


Inventors:

David Neville (NIMH)  ➽ more inventions...


Intellectual Property:
US Pat: 7,696,338 issued 2010-04-13
US Pat: 6,632,928 issued 2003-10-14
US Pat: 7,288,254 issued 2007-10-30
US Pat: 7,125,553 issued 2006-10-24
US Pat: 6,103,235 issued 2000-08-15
US Pat: 5,167,956 issued 1992-12-01
US Pat: 5,762,927 issued 1998-06-09
US Pat: 8,217,158 issued 2012-07-10
US Pat: 8,987,426 issued 2015-03-24
US Application No. 09/573,797 filed on 2000-05-18
US Application No. 13/443,779 filed on 2012-04-10
US Application No. 07/907,409 filed on 1992-07-01
PCT Application No. PCT/US92/000813 filed on 1992-02-11
US Application No. 60/039,987 filed on 1997-03-05
PCT Application No. PCT/US98/04303 filed on 1998-03-05
US Application No. 10/435,567 filed on 2003-05-09
US Application No. 09/064,413 filed on 1998-04-22
PCT Application No. PCT/US99/08606 filed on 1999-04-20
US Application No. 09/636,251 filed on 2000-08-10
Foreign rights may also available.

Licensing Contact:
Jennifer Wong, M.S.
Email: jennifer.wong2@nih.gov
Phone: 301-480-4821

OTT Reference No: E-012-1991-0
Updated: Nov 9, 2015